CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

risk/reward

  1. 299 Posts.
    The risks on the downside are obvious. Not very much will be left. On the other hand the upside provides for a multiple of many times the current share price.That being said the product has considerable theraputic [ie life giving] benefit. In those circmstance logic dictates the product will be approved for use.There is demand[which is growing] for the product.If approved the numbers are compelling.Time will provide a considerable profit.Some patience is recquired in the short term. Some are yet to crystalize recent losses.
 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.